Allison Rodriguez, DMD
Oral and Maxillofacial Surgery · Philadelphia, PANPI 1538447040
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,550 of the $3,893 with a category attached, or 91.2%. Zimvie Inc. accounts for 91.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $2,475 and has fallen 87.7% since, to $305 in 2025.
Across 67 payments — averaging $58.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimvie Inc.$4K
- Zimmer Biomet$148
- American Medical & Dental Supplies,inc.$75
- Straumann USA LLC$66
- Exeltis, USA Inc.$36
What the payments were for
- Food & beverage$2687%
- Education$3,55091%
- Gifts$752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimvie Inc. | 54 | $3,568 |
| Zimmer Biomet | 8 | $148 |
| American Medical & Dental Supplies,inc. | 1 | $75 |
| Straumann USA LLC | 2 | $66 |
| Exeltis, USA Inc. | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,893 in reported general payments places this provider in the 85th percentile of 369 oral and maxillofacial surgery providers in Pennsylvania.
See all oral and maxillofacial surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 179 | $372 |
| Clindamycin Hcl | 26 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $109 |
| Chlorhexidine Gluconate | 21 | $58 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Philadelphia
- Neeraj PanchalPhiladelphia$73K
- Eric GranquistPhiladelphia$65K
- Bradley HershPhiladelphia$20K
- Andrew YampolskyPhiladelphia$6K
- John MasiPhiladelphia$4K
- Justin BurnsPhiladelphia$3K
- Frank DorobaPhiladelphia$3K
- Lauren TragerPhiladelphia$3K
- Akshar YagnikPhiladelphia$3K
- Berfin KaratasPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.